SBFM logo

Sunshine Biopharma (SBFM) Company Overview

Profile

Full Name:

Sunshine Biopharma, Inc.

Sector:

Healthcare

Country:

United States

IPO:

February 15, 2022

Indexes:

Not included

Description:

Sunshine Biopharma (SBFM) is a biotechnology company focused on developing innovative drugs for cancer treatment. They aim to create effective therapies using advanced research and technology, addressing unmet medical needs in oncology. Their commitment to improving patient outcomes drives their research and development efforts.

Key Details

Price

$2.27

Annual Revenue

$24.09 M(+454.42% YoY)

Annual EPS

-$380.00(+89.20% YoY)

Annual ROE

-21.04%

Beta

1.00

Events Calendar

Earnings

Next earnings date:

May 20, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 8, 2024

Analyst ratings

Recent major analysts updates

Dec 5, 24 Aegis Capital
Buy
Aug 7, 23 Aegis Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Sunshine Biopharma?
  • Does Sunshine Biopharma pay dividends?
  • What sector is Sunshine Biopharma in?
  • What industry is Sunshine Biopharma in?
  • What country is Sunshine Biopharma based in?
  • When did Sunshine Biopharma go public?
  • Is Sunshine Biopharma in the S&P 500?
  • Is Sunshine Biopharma in the NASDAQ 100?
  • Is Sunshine Biopharma in the Dow Jones?
  • When was Sunshine Biopharma's last earnings report?
  • When does Sunshine Biopharma report earnings?
  • Should I buy Sunshine Biopharma stock now?

What is the ticker symbol for Sunshine Biopharma?

The ticker symbol for Sunshine Biopharma is NASDAQ:SBFM

Does Sunshine Biopharma pay dividends?

No, Sunshine Biopharma does not pay dividends

What sector is Sunshine Biopharma in?

Sunshine Biopharma is in the Healthcare sector

What industry is Sunshine Biopharma in?

Sunshine Biopharma is in the Drug Manufacturers - Specialty & Generic industry

What country is Sunshine Biopharma based in?

Sunshine Biopharma is headquartered in United States

When did Sunshine Biopharma go public?

Sunshine Biopharma's initial public offering (IPO) was on February 15, 2022

Is Sunshine Biopharma in the S&P 500?

No, Sunshine Biopharma is not included in the S&P 500 index

Is Sunshine Biopharma in the NASDAQ 100?

No, Sunshine Biopharma is not included in the NASDAQ 100 index

Is Sunshine Biopharma in the Dow Jones?

No, Sunshine Biopharma is not included in the Dow Jones index

When was Sunshine Biopharma's last earnings report?

Sunshine Biopharma's most recent earnings report was on Nov 5, 2024

When does Sunshine Biopharma report earnings?

The next expected earnings date for Sunshine Biopharma is May 20, 2025

Should I buy Sunshine Biopharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions